• Medicalgorithmics signed an agreement with a U.S. medical technology company specializing in ambulatory cardiac monitoring.
• The partnership will integrate its DeepRhythmPlatform software and DeepRhythmAI algorithms with the partner’s devices.
• The agreement secures at least USD 200,000 in first-year revenue through minimum guaranteed fees and an integration fee.
• Initial revenue is expected before the end of 2026; usage-based fees will depend on the volume of studies analyzed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medicalgorithmics SA published the original content used to generate this news brief on November 09, 2026, and is solely responsible for the information contained therein.